Argan (AGX) Misses Q1 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AGX Hot Sheet
Price: $290.66 -16.53%
Revenue Growth %: +41.1%
Financial Fact:
Income from operations: 26.73M
Today's EPS Names:
ARIS, COHR, ATS, More
Revenue Growth %: +41.1%
Financial Fact:
Income from operations: 26.73M
Today's EPS Names:
ARIS, COHR, ATS, More
Join SI Premium – FREE
Argan (NYSE: AGX) reported Q1 EPS of $0.58, $0.14 worse than the analyst estimate of $0.72. Revenue for the quarter came in at $157.68 million versus the consensus estimate of $144.6 million.
For earnings history and earnings-related data on Argan (AGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Myriad Genetics (MYGN) Tops Q3 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
